Literature DB >> 7655174

Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.

W M Kohrt1, S J Birge.   

Abstract

It is commonly believed that estrogen is effective only in preventing menopause-related loss of bone mineral. However, recent studies found significant increases in bone mineral density (BMD) of the spine in response to estrogen, particularly in older women. The degree to which estrogen can restore BMD of the hip is uncertain. In the present study, changes in BMD of the lumber spine (L2-4), hip (neck, trochanter and Ward's triangle), wrist (ultradistal) and total body in response to 1 year of hormone replacement therapy (HRT) were evaluated by dual-energy X-ray absorptiometry (DXA) in women 10 or more years past menopause. Twelve women, aged 61-74 years, received conjugated estrogens 0.625 mg and cyclic medroxyprogesterone acetate 5 mg; 12 women who did not receive HRT were controls. Calcium intake was adjusted to approximately 1500 mg/day in all subjects. There were no differences between the groups in BMD prior to treatment. Increases in BMD of the lumbar spine (mean +/- SD, 0.041 +/- 0.030 g/cm2), hip (neck, 0.019 +/- 0.018 g/cm2; trochanter, 0.017 +/- 0.012 g/cm2; Ward's triangle, 0.026 +/- 0.029 g/cm2) and total body (0.013 +/- 0.016 g/cm2) occurred in response to HRT, and these changes were significantly different from those in controls (spine, 0.005 +/- 0.020 g/cm2; neck, -0.007 +/- 0.026 g/cm2; trochanter, 0.002 +/- 0.014 g/cm2; Ward's triangle, 0.003 +/- 0.019 g/cm2; total body, -0.001 +/- 0.017 g/cm2). HRT appears to be most effective at weight-bearing sites that have a high cancellous bone content.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655174     DOI: 10.1007/bf02106093

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.

Authors:  L E Nachtigall; R H Nachtigall; R D Nachtigall; E M Beckman
Journal:  Obstet Gynecol       Date:  1979-03       Impact factor: 7.661

Review 2.  The role of changes in mechanical usage set points in the pathogenesis of osteoporosis.

Authors:  H M Frost
Journal:  J Bone Miner Res       Date:  1992-03       Impact factor: 6.741

Review 3.  Homeostatic control of bone structure: an application of feedback theory.

Authors:  C H Turner
Journal:  Bone       Date:  1991       Impact factor: 4.398

4.  Comparative assessment of dual-photon absorptiometry and dual-energy radiography.

Authors:  C C Glüer; P Steiger; R Selvidge; K Elliesen-Kliefoth; C Hayashi; H K Genant
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

5.  The minimum effective dose of estrogen for prevention of postmenopausal bone loss.

Authors:  R Lindsay; D M Hart; D M Clark
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

6.  Estrogen therapy arrests bone loss in elderly women.

Authors:  M E Quigley; P L Martin; A M Burnier; P Brooks
Journal:  Am J Obstet Gynecol       Date:  1987-06       Impact factor: 8.661

7.  Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

Authors:  J C Gallagher; W T Kable; D Goldgar
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

8.  Treatment of postmenopausal osteoporosis with transdermal estrogen.

Authors:  E G Lufkin; H W Wahner; W M O'Fallon; S F Hodgson; M A Kotowicz; A W Lane; H L Judd; R H Caplan; B L Riggs
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

9.  Age-related differences in body composition by hydrodensitometry and dual-energy X-ray absorptiometry.

Authors:  D B Snead; S J Birge; W M Kohrt
Journal:  J Appl Physiol (1985)       Date:  1993-02

Review 10.  Estrogens in the prevention of osteoporosis in postmenopausal women.

Authors:  H K Genant; D J Baylink; J C Gallagher
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

View more
  5 in total

1.  Association of a T262C transition in exon 1 of estrogen-receptor-alpha gene with skeletal responsiveness to estrogen in post-menopausal women.

Authors:  B Ongphiphadhanakul; S Chanprasertyothin; P Payattikul; S Saetung; N Piaseu; L Chailurkit; S Chansirikarn; G Puavilai; R Rajatanavin
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

2.  Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy.

Authors:  Scott Going; Timothy Lohman; Linda Houtkooper; Lauve Metcalfe; Hilary Flint-Wagner; Robert Blew; Vanessa Stanford; Ellen Cussler; Jane Martin; Pedro Teixeira; Margaret Harris; Laura Milliken; Arturo Figueroa-Galvez; Judith Weber
Journal:  Osteoporos Int       Date:  2003-07-03       Impact factor: 4.507

3.  Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.

Authors:  Mariska C Vlot; Chantal M Wiepjes; Renate T de Jongh; Guy T'Sjoen; Annemieke C Heijboer; Martin den Heijer
Journal:  J Bone Miner Res       Date:  2019-08-19       Impact factor: 6.741

4.  Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.

Authors:  Chantal M Wiepjes; Renate T de Jongh; Christel Jm de Blok; Mariska C Vlot; Paul Lips; Jos Wr Twisk; Martin den Heijer
Journal:  J Bone Miner Res       Date:  2018-12-07       Impact factor: 6.741

5.  Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis.

Authors:  Ling Qin; Wingyee Choy; Szeki Au; Musei Fan; Pingchung Leung
Journal:  J Orthop Surg Res       Date:  2007-05-21       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.